Royal Bank of Canada’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Buy |
3,085
+2,571
| +500% | +$5K | ﹤0.01% | 6229 |
|
|
2025
Q1 | $4K | Buy |
514
+156
| +44% | +$1.21K | ﹤0.01% | 6054 |
|
|
2024
Q4 | $8K | Sell |
358
-293
| -45% | -$6.55K | ﹤0.01% | 5925 |
|
|
2024
Q3 | $14K | Buy |
651
+124
| +24% | +$2.67K | ﹤0.01% | 5773 |
|
|
2024
Q2 | $9K | Buy |
527
+432
| +455% | +$7.38K | ﹤0.01% | 6008 |
|
|
2024
Q1 | $4K | Sell |
95
-1,216
| -93% | -$51.2K | ﹤0.01% | 6089 |
|
|
2023
Q4 | $33K | Buy |
1,311
+710
| +118% | +$17.9K | ﹤0.01% | 5620 |
|
|
2023
Q3 | $20K | Buy |
601
+260
| +76% | +$8.65K | ﹤0.01% | 5689 |
|
|
2023
Q2 | $20K | Buy |
+341
| New | +$20K | ﹤0.01% | 5768 |
|
|
2022
Q4 | – | Sell |
-3
| Closed | – | – | 7209 |
|
|
2022
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 7345 |
|
|
2021
Q3 | – | Sell |
-69
| Closed | -$13K | – | 7280 |
|
|
2021
Q2 | $13K | Buy |
69
+12
| +21% | +$2.26K | ﹤0.01% | 6275 |
|
|
2021
Q1 | $15K | Buy |
57
+28
| +97% | +$7.37K | ﹤0.01% | 6109 |
|
|
2020
Q4 | $6K | Buy |
29
+28
| +2,800% | +$5.79K | ﹤0.01% | 6046 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6382 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | -$1K | – | 6352 |
|
|
2020
Q1 | $1K | Sell |
3
-28
| -90% | -$9.33K | ﹤0.01% | 5997 |
|
|
2019
Q4 | $10K | Buy |
31
+22
| +244% | +$7.1K | ﹤0.01% | 5546 |
|
|
2019
Q3 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 5567 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | – | – | 6152 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6276 |
|